Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Stroke. 2023 Feb 27;54(3):648–660. doi: 10.1161/STROKEAHA.122.038265

Table 3.

Use of antiplatelet therapy in patients with MCI or dementia and CSVD.

Recent small subcortical infarct Lacune of presumed vascular origin with symptomatic atherosclerosis Lacune of presumed vascular origin without symptomatic atherosclerosis Lacune of presumed vascular origin with >5–10 CMBs and no symptomatic atherosclerosis CSVD without lacunes, with symptomatic atherosclerosis CSVD without lacunes, without symptomatic atherosclerosis
Indicated SAPT & DAPT SAPT SAPT
Possibly indicated SAPT SAPT
Contraindicated DAPT DAPT SAPT & DAPT DAPT DAPT

CMB denotes cerebral microbleeds; DAPT, dual antiplatelet therapy; and SAPT, single antiplatelet therapy.